Australia's E-Cigarette Rules Fizzle with Only 3,500 Prescriptions in First Month

Nov.11.2024
Australia's E-Cigarette Rules Fizzle with Only 3,500 Prescriptions in First Month
Australia’s new plan to include e-cigarettes in pharmacies saw slow sales in its first month, with only 3,500 units sold. Many pharmacists are reluctant to sell e-cigarettes due to ethical concerns or complicated procedures, leading to a surge in black market e-cigarette prices to 40-60 AUD.

According to a report from Watoday on November 9, despite an estimated one million Australians using e-cigarettes, in a plan implemented by the federal government to include e-cigarettes as pharmacy products to combat the black market, only 3,500 sales were made in the first month.

 

Australia has approximately 5800 pharmacies nationwide, but data shows that thousands of them do not dispense any e-cigarette products on prescription. The federal government's initial policy analysis assumed that once illegal products are harder to obtain, about 450,000 people will seek medical e-cigarette products.

 

However, many pharmacists have stated that they are unwilling to sell e-cigarettes due to moral reasons or because the process is too cumbersome. Illegal e-cigarettes are still widely available, but prices have soared to 40 to 60 Australian dollars per device as retailers increase prices to compensate for higher penalties.

 

Last week, officials at a Senate estimates hearing stated that they currently do not track how many pharmacies are selling e-cigarettes. Chief Medical Officer Tony Lawler said that obtaining a definitive answer is actually quite difficult.

 

Health Department official Chris Bedford provided data on the sale of e-cigarette products by pharmacies following patient consultations. He stated that the total number of these sales across Australia reached 3,500, and pharmacists are able to dispense multiple e-cigarette products based on notification, leading to patients coming in and engaging in conversations.

 

Anne Ruston, the Health spokesperson for the opposition party, stated that the number of e-cigarettes sold by pharmacies last month only accounted for a small fraction of estimated e-cigarette users in Australia.

 

"We know that most pharmacists do not want to become tobacco merchants, as clearly reflected in the department's statistics."

 

Due to e-cigarette products not being included in Australia's registered therapeutic goods list, pharmacists must prescribe and sell unapproved products. This has made pharmacists cautious about supplying e-cigarettes. Data from the pharmacy industry shows that the majority of people are not willing to stock e-cigarettes, with a survey finding that 86% of pharmacies do not stock them.

 

Richard Lee, CEO of pharmaceutical company Liber Pharmaceuticals, stated that despite a slow start, the pharmacy's e-cigarette program is progressing within a reasonable range. The slow progress is partially due to the timing of the introduction of new regulations and the implementation phase. Lee expects pharmacies to gradually adapt to the new regulations and achieve significant growth within the next three to six months.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
EUIPO Rejects Imiracle’s Opposition to ‘Crystal’ Trademark, Citing Lack of Proof of Actual Use in Slovakia
The EUIPO has ruled that Imiracle failed to demonstrate actual commercial use of its “Elfbar Crystal” brand in Slovakia, and therefore rejected in full the company’s opposition to Shenzhen SKE Technology’s application to register the “Crystal” trademark. The EUIPO noted that the sales records submitted by Imiracle were limited in scope and that the product packaging was in Ukrainian, which it found insufficient to prove that the products had been placed on the Slovak market.
Dec.10 by 2FIRSTS.ai
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco launches limited-edition Ploom AURA color “Bronze Royal,” priced at about $27
Japan Tobacco (JT) announced that Ploom AURA has added a second limited-edition colorway, “Bronze Royal,” which will be available in limited quantities through official channels starting November 11, priced at approximately $27.3.
Nov.12 by 2FIRSTS.ai
FCTC: Global tobacco control treaties to address nicotine addiction, tobacco’s impact on the environment and illicit tobacco trade
FCTC: Global tobacco control treaties to address nicotine addiction, tobacco’s impact on the environment and illicit tobacco trade
More than 1,400 delegates will gather in Geneva as two major global tobacco control treaties convene to address rising nicotine addiction, environmental harms, and illicit tobacco trade—key discussions that could shape the future of global tobacco control policy.
Nov.14
KT&G Revises Partnership Terms with PMI, Secures Overseas Commercialization Rights for Multiple Heated Tobacco Platforms
KT&G Revises Partnership Terms with PMI, Secures Overseas Commercialization Rights for Multiple Heated Tobacco Platforms
KT&G has revised the terms of its 15-year partnership agreement with Philip Morris International (PMI), securing overseas commercialization rights for multiple heated tobacco platforms and adjusting the minimum guaranteed sales volume for lil-exclusive heated tobacco sticks from 16 billion units to 11 billion units.
Dec.12 by 2FIRSTS.ai
Switzerland's Geneva to enforce ban on disposable e-cigarettes following court ruling
Switzerland's Geneva to enforce ban on disposable e-cigarettes following court ruling
The Canton of Geneva has begun enforcing its ban on disposable e-cigarettes (“puffs”) after the cantonal court rejected industry appeals to suspend the law. Passed on August 29 by the Grand Council, the ban will now be actively monitored by trade inspectors, while a similar measure is already in force in Valais.
Nov.07 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26